NEW DELHI: The island kingdom of Bahrain is said to be the second nation in the world to grant an emergency-use authorization for the coronavirus vaccine. The coronavirus vaccine is made by Pfizer and its German partner Bio-NTech.
The state-run Bahrain News Agency made the announcement saying “thorough analysis and review of all available data,” on Friday night granting an emergency-use approval for a Chinese vaccine by Sinopharm. They did not disclose how many vaccines it has purchased, nor when vaccinations would begin. It did not immediately respond to questions from The Associated Press. Pfizer later told the AP that the details of its sales agreement with Bahrain, including the “timing of delivery and the volume of doses,” were confidential and refused to comment. Pfizer said “We have developed detailed logistical plans and tools to support effective vaccine transport, storage, and continuous temperature monitoring. Our distribution is built on a flexible just in time system which will ship the frozen vials to the point of vaccination.” The condition bounding Bahrain is the storage of the vaccine. They must be stored and shipped at ultra-cold temperatures of around minus 70 degrees Celsius. Bahrain is a Mideast nation that regularly sees temperatures in the summer of around 40 degrees Celsius with high humidity.
The vaccine will require two doses to be given three weeks apart. Bahrain had already granted emergency-use authorization for a Chinese vaccine made by Sinopharm and has inoculated some 6,000 people with it.
Also Read:-
Resolution of Gulf dispute seems within reach: Saudi Arabia
'Not Certain' if the vaccine will prevent Covid 19 transmission, Pfizer CEO
China to construct 10000 Kilometres railway over next five years